Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents

A. Stefani, A. Pisani, M. De Murtas, N. B. Mercuri, M. G. Marciani, P. Calabresi

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

GP 47779, the active metabolite of oxcarbazepine (OCBZ) inhibits glutamatergic excitatory postsynaptic potentials (EPSPs) in rat striatum (described in the accompanying article). This effect was presumed to involve the modulation of the calcium (Ca2+) signals at either pre- or postsynaptic level. Therefore, we directly tested whether GP 47779 could modulate Ca2+ conductances in cortical as well as in striatal neurons. GP 47779 produced a reversible dose-dependent decrease in high-voltage-activated (HVA) Ca2+ currents evoked by membrane depolarization in isolated cortical pyramidal cells. GP 47779-mediated reduction in HVA Ca2+ currents, if occurring also at corticostriatal axon terminals, might explain the reduction of glutamate release in the striatum. An inhibitory action of GP 47779 on HVA Ca2+ currents was also observed in isolated striatal neurons. The effect on HVA Ca2+ currents in cortical and striatal neurons persisted in the presence of nifedipine, suggesting that dihydropyridine-sensitive channels were not involved in the GP 47779-mediated responses. We propose that the modulation of HVA Ca2+ channels by this carbamazepine (CBZ) analogue may account for its inhibitory action on transmitter release.

Original languageEnglish
Pages (from-to)997-1002
Number of pages6
JournalEpilepsia
Volume36
Issue number10
DOIs
Publication statusPublished - 1995

Fingerprint

10,11-dihydro-10-hydroxycarbamazepine
Calcium
Corpus Striatum
Neurons
Pyramidal Cells
Excitatory Postsynaptic Potentials
Carbamazepine
Presynaptic Terminals
Nifedipine
oxcarbazepine
Glutamic Acid

Keywords

  • Calcium currents
  • Cortex
  • Epilepsy
  • Striatum
  • Whole-cell patch clamp

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. / Stefani, A.; Pisani, A.; De Murtas, M.; Mercuri, N. B.; Marciani, M. G.; Calabresi, P.

In: Epilepsia, Vol. 36, No. 10, 1995, p. 997-1002.

Research output: Contribution to journalArticle

@article{06af9afbb89d479fa6ab661d8275769c,
title = "Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents",
abstract = "GP 47779, the active metabolite of oxcarbazepine (OCBZ) inhibits glutamatergic excitatory postsynaptic potentials (EPSPs) in rat striatum (described in the accompanying article). This effect was presumed to involve the modulation of the calcium (Ca2+) signals at either pre- or postsynaptic level. Therefore, we directly tested whether GP 47779 could modulate Ca2+ conductances in cortical as well as in striatal neurons. GP 47779 produced a reversible dose-dependent decrease in high-voltage-activated (HVA) Ca2+ currents evoked by membrane depolarization in isolated cortical pyramidal cells. GP 47779-mediated reduction in HVA Ca2+ currents, if occurring also at corticostriatal axon terminals, might explain the reduction of glutamate release in the striatum. An inhibitory action of GP 47779 on HVA Ca2+ currents was also observed in isolated striatal neurons. The effect on HVA Ca2+ currents in cortical and striatal neurons persisted in the presence of nifedipine, suggesting that dihydropyridine-sensitive channels were not involved in the GP 47779-mediated responses. We propose that the modulation of HVA Ca2+ channels by this carbamazepine (CBZ) analogue may account for its inhibitory action on transmitter release.",
keywords = "Calcium currents, Cortex, Epilepsy, Striatum, Whole-cell patch clamp",
author = "A. Stefani and A. Pisani and {De Murtas}, M. and Mercuri, {N. B.} and Marciani, {M. G.} and P. Calabresi",
year = "1995",
doi = "10.1111/j.1528-1157.1995.tb00958.x",
language = "English",
volume = "36",
pages = "997--1002",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "10",

}

TY - JOUR

T1 - Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents

AU - Stefani, A.

AU - Pisani, A.

AU - De Murtas, M.

AU - Mercuri, N. B.

AU - Marciani, M. G.

AU - Calabresi, P.

PY - 1995

Y1 - 1995

N2 - GP 47779, the active metabolite of oxcarbazepine (OCBZ) inhibits glutamatergic excitatory postsynaptic potentials (EPSPs) in rat striatum (described in the accompanying article). This effect was presumed to involve the modulation of the calcium (Ca2+) signals at either pre- or postsynaptic level. Therefore, we directly tested whether GP 47779 could modulate Ca2+ conductances in cortical as well as in striatal neurons. GP 47779 produced a reversible dose-dependent decrease in high-voltage-activated (HVA) Ca2+ currents evoked by membrane depolarization in isolated cortical pyramidal cells. GP 47779-mediated reduction in HVA Ca2+ currents, if occurring also at corticostriatal axon terminals, might explain the reduction of glutamate release in the striatum. An inhibitory action of GP 47779 on HVA Ca2+ currents was also observed in isolated striatal neurons. The effect on HVA Ca2+ currents in cortical and striatal neurons persisted in the presence of nifedipine, suggesting that dihydropyridine-sensitive channels were not involved in the GP 47779-mediated responses. We propose that the modulation of HVA Ca2+ channels by this carbamazepine (CBZ) analogue may account for its inhibitory action on transmitter release.

AB - GP 47779, the active metabolite of oxcarbazepine (OCBZ) inhibits glutamatergic excitatory postsynaptic potentials (EPSPs) in rat striatum (described in the accompanying article). This effect was presumed to involve the modulation of the calcium (Ca2+) signals at either pre- or postsynaptic level. Therefore, we directly tested whether GP 47779 could modulate Ca2+ conductances in cortical as well as in striatal neurons. GP 47779 produced a reversible dose-dependent decrease in high-voltage-activated (HVA) Ca2+ currents evoked by membrane depolarization in isolated cortical pyramidal cells. GP 47779-mediated reduction in HVA Ca2+ currents, if occurring also at corticostriatal axon terminals, might explain the reduction of glutamate release in the striatum. An inhibitory action of GP 47779 on HVA Ca2+ currents was also observed in isolated striatal neurons. The effect on HVA Ca2+ currents in cortical and striatal neurons persisted in the presence of nifedipine, suggesting that dihydropyridine-sensitive channels were not involved in the GP 47779-mediated responses. We propose that the modulation of HVA Ca2+ channels by this carbamazepine (CBZ) analogue may account for its inhibitory action on transmitter release.

KW - Calcium currents

KW - Cortex

KW - Epilepsy

KW - Striatum

KW - Whole-cell patch clamp

UR - http://www.scopus.com/inward/record.url?scp=0029082313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029082313&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1157.1995.tb00958.x

DO - 10.1111/j.1528-1157.1995.tb00958.x

M3 - Article

C2 - 7555964

AN - SCOPUS:0029082313

VL - 36

SP - 997

EP - 1002

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 10

ER -